Navigation Links
Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
Date:12/11/2008

    NEW YORK, Dec. 11 /PRNewswire-FirstCall/ --

    -- Innovation and Patient-Centered Approach Expected to Drive Future
       Success
    -- Lilly Climbs into Top 10 Pharmaceutical Companies in Worldwide Sales
       and Is Fastest Growing in U.S.
    -- FIPNet Strategy Expands Global Reach and Improves R&D Productivity
    -- Company Aims to Reduce Cost of Bringing New Medicine to Market from
       $1.2 Billion to $800 Million by 2010.
    -- R&D Pipeline Boasts Unprecedented 59 Molecules in Clinical Development
    -- Investment in Biotechnology Capabilities Results in Expanded Large
       Molecule Portfolio
    -- ImClone Acquisition Creates Leading Oncology Franchise
    -- 2009 EPS Guidance Set at $4.00 to $4.25, Including $.30 to $.35 of
       ImClone Dilution
    -- Excluding ImClone Dilution, 2009 EPS Expected to be $4.35 to $4.55

At its annual meeting with the investment community, Eli Lilly and Company (NYSE: LLY) today highlighted progress on its expanding pipeline of innovative molecules and marketed medicines, provided investors with sales and earnings guidance for 2009, and reviewed the transformation efforts that the company is making to excel in an increasingly challenging healthcare environment.

"Lilly continues to deliver strong financial results to our shareholders through an attractive combination of volume-based sales growth for key marketed products and an ongoing commitment to productivity and cost containment," commented John C. Lechleiter, Ph.D., Lilly's president and chief executive officer. "Our scientists are dedicated to maximizing the potential of our pipeline, which now boasts an unprecedented 59 molecules in clinical development, 40 percent of which are biotech-based. Lilly's success depends on innovation, and the promising molecules we are discussing at today's m
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... If you plan to attend the ... October, you will also want to sign up for the tour of Framingham State ... tour includes a walk through of the (8) chemistry teaching labs that are exclusively ...
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Biochips and Microarrays ... offering. This report is an analysis ... The report starts with a description of technologies ... include array comparative genomic hybridization (CGH), copy number ...
(Date:9/2/2015)... -- Biovista Inc. is glad to announce ... science challenge, a global competition hosted by the Rare ... the latest life science innovations and technologies. ... capability to support Steven Laffoon and his ... Niemann-Pick Disease Type A (NPA), a rare and fatal ...
(Date:9/2/2015)... , Sept. 2, 2015 Veracyte, Inc. ... H. Anderson , president and chief executive officer, will ... Wednesday, September 16, 2015 at 10:30 a.m. ET in ... The live audio webcast and subsequent replay may ... webcast will be available shortly after conclusion of the ...
Breaking Biology Technology:Erlab Invites You to Tour the Largest Installation of Filtered Fume Hoods in the World 2Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Veracyte to Present at Morgan Stanley Global Healthcare Conference 2
... 2010 (BRONX, NY) By constructing a microscope ... cells, researchers at Albert Einstein College of Medicine ... that occur during one of the most important "trips" ... Ribonucleic acid (RNA) molecules from the nucleus into the ...
... Therapies, Inc., (VTI) is pleased to announce that ... in Riyadh, Kingdom of Saudi Arabia (K.S.A.) in the further ... L i VER Failure) clinical trial to the ... therapy product, ELAD®, can prevent deterioration of liver function and ...
... BASKING RIDGE, N.J., Sept. 16 Regado Biosciences, a ... with active control agents, announced that David J. Mazzo, ... UBS Global Life Sciences Conference.  Dr. Mazzo,s presentation will ... York City on Wednesday, September 22, 2010 at 8:00 ...
Cached Biology Technology:Nature study shows how molecules escape from the nucleus 2Nature study shows how molecules escape from the nucleus 3Vital Therapies Expands SILVER Trial to Saudi Arabia 2Vital Therapies Expands SILVER Trial to Saudi Arabia 3Vital Therapies Expands SILVER Trial to Saudi Arabia 4Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City 2Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City 3
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics ... of human interface solutions, today announced collaboration with ... on Windows 10. Microsoft leveraged Synaptics, deep expertise ... operating system. Through stringent testing, ... fully certified with Microsoft,s Precision TouchPad (PTP) specification ...
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... from apes to humans may have been partially triggered by ... safely carry heavier babies. This theory1 of species evolution presented ... Brazil has just been published online in Springers journal, Naturwissenschaften. ... to their fur from birth, and species survival depends on ...
... A before-and-after study led by Yale biologists, of the ... of marine iguanas on the Galpagos Islands, emphasizes the ... to determine which environmental and biological factors make specific ... authors, recurring El Nio events provide an ideal system ...
... on Emerging Nanotechnologies released the results of a new ... how firms in almost every sector of the economy ... of new nanoscale materials and products. The survey found ... EHS expectations and regulations for successful commercialization, as well ...
Cached Biology News:Walking tall to protect the species 2Global climate change: The impact of El Niño on Galápagos marine iguanas 2Nanotech companies need clear environment and health roadmap to succeed 2
... Data System (CDS) now provides integrated ... data processing and reporting for the ... The companys innovative HPLC instrument has ... of Thermo Scientific Hypersil GOLD 1.9 ...
...
...
... technology enables sensitive and specific detection of ... Detection probes have high binding affinity and ... of miRNAs. Due to the high binding ... than 1/10 the amount of sample is ...
Biology Products: